Learn More

This week's Fierce Biotech is brought to you by IQVIA.

Trouble viewing? Click here.


 
 
Detailed country and site strategy supports data-informed decision making
 
A mid-sized pharmaceutical company was planning to launch a global, multi-trial solid tumor program with the same compound. IQVIA’s Clinical Trial Analytics Services were employed to provide data-informed recommendations across the program, including proposed risk mitigation for each study’s unique potential challenges. Domain experts collaborated to deliver a robust, program-level country and site strategy across the sponsor’s six oncology studies to help the sponsor prove that the plan was operationally feasible.
 
 
IQVIA’S CLINICAL TRIAL ANALYTICS SERVICES CAN HELP SPONSORS PLAN COMPLEX TRIAL STRATEGIES

Read the case study to find out how IQVIA helped inform an oncology clinical trial strategy across 6 studies globally.
READ THE CASE STUDY 
 
Clinical Trial Analytics Services
 

IQVIA’s Clinical Trial Analytics Services can help you connect real-world data, machine learning and clinical expertise to reduce risk, improve timelines and accelerate enrollment.
 
LEARN MORE


Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.



You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor  
New York, NY 10017